RTA Laboratories have been founded in 1996. Having started its R & D studies by supporting a TÜBITAK project in 2011, RTA settled in to its own building in Gebze Plastikçiler Organized Industrial Zone. In the same year, The R&D laboratory which is suitable for molecular biology-genetic, immunology-serology-based studies was founded. In 2004, suitable R&D laboratory and clean rooms have been established for the research and production of medical and industrial biotechnology. In 2014, the first and only bio-tech public listed company in Istanbul Stock Exchange. RTA Laboratories is being traded with a code of “RTALB” in ISE. RTA Laboratories offered 34% of its shares to public as a state-of-art biotechnology company.
The RTA is in close contact with the scientific community, industrial firms, clinics, universities and research organizations related to their subjects. In 2017, RTA Laboratories received a R & D Center certificate from the Ministry of Science, Industry and Technology. In 2018, Güler Yatırım A.Ş. was purchased by.RTA Laboratories maintains R & D and production activities under Güler Yatırım A.Ş. management.
In 2019, with the subsidiary of A1 Yaşam Bilimleri A.Ş., RTA Labs accelerated and strengthened marketing activities in the field of diagnostics and life sciences.